A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: design, in vitro and 'in vivo' evaluation
- PMID: 17920795
- DOI: 10.1016/j.ijpharm.2007.08.042
A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: design, in vitro and 'in vivo' evaluation
Abstract
Bioadhesive tablet formulations of ketoconazole for vaginal delivery were studied. Carbomer (Carbopol 974P, Carbopol 934P), hydroxypropylmethyl cellulose (HPMC) and hydroxypropyl cellulose (HPC) were used as candidate bioadhesive polymers. Effervescent was incorporated into the formulations as a disintegration agent. The swelling behavior and bioadhesive strength of the drug-free tablets were investigated. Carbopol 934P was selected as biopolymer in combination with HPMC or HPC at different ratios to develop five drug-loaded formulations. The swellings, tackiness and in vitro release were studied on the tablets. A good sustained effect and a moderate bioadhesion were obtained with the tablets. The formulation containing 100mg of effervescent, with the Carbopol 934P:HPC ratio of 1:9, seemed to be the optimum one for the tablet. In vivo drug residence tests were carried out by administering the preferred formulation to female rats. The results showed that the drug remaining followed a one-order model. Even after 24h of administration in vagina of rats, 17% of the original employed drug was retained on the vaginal tissue. Our study may provide a potential vaginal tablet formulation of ketoconazole against Candida albicans.
Similar articles
-
Studies on vaginal bioadhesive tablets of acyclovir.Pharmazie. 2000 Apr;55(4):297-9. Pharmazie. 2000. PMID: 10798244
-
Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans.Farmaco. 2004 Feb;59(2):163-7. doi: 10.1016/j.farmac.2003.11.018. Farmaco. 2004. PMID: 14871509
-
Once daily bioadhesive vaginal clotrimazole tablets: design and evaluation.Acta Pharm. 2006 Sep;56(3):337-45. Acta Pharm. 2006. PMID: 19831282
-
Innovations in bioadhesive vaginal drug delivery system.Expert Opin Ther Pat. 2012 Sep;22(9):1019-32. doi: 10.1517/13543776.2012.714369. Epub 2012 Aug 4. Expert Opin Ther Pat. 2012. PMID: 22860765 Review.
-
The vagina as a route for systemic drug delivery.J Control Release. 2005 Mar 21;103(2):301-13. doi: 10.1016/j.jconrel.2004.11.034. Epub 2005 Jan 13. J Control Release. 2005. PMID: 15763615 Review.
Cited by
-
Design expert assisted formulation of topical bioadhesive gel of sertaconazole nitrate.Adv Pharm Bull. 2014;4(2):121-30. doi: 10.5681/apb.2014.019. Epub 2013 Dec 24. Adv Pharm Bull. 2014. PMID: 24511475 Free PMC article.
-
Investigation of the physicochemical and physicomechanical properties of a novel intravaginal bioadhesive polymeric device in the pig model.AAPS PharmSciTech. 2010 Jun;11(2):793-808. doi: 10.1208/s12249-010-9439-3. Epub 2010 May 6. AAPS PharmSciTech. 2010. PMID: 20446071 Free PMC article.
-
Role of chitosan on controlling the characteristics and antifungal activity of bioadhesive fluconazole vaginal tablets.Saudi Pharm J. 2018 Feb;26(2):151-161. doi: 10.1016/j.jsps.2017.12.016. Epub 2017 Dec 23. Saudi Pharm J. 2018. PMID: 30166911 Free PMC article.
-
Improved Transmucosal Delivery of Glimepiride via Unidirectional Release Buccal Film Loaded With Vitamin E TPGS-Based Nanocarrier.Dose Response. 2020 Jul 31;18(3):1559325820945164. doi: 10.1177/1559325820945164. eCollection 2020 Jul-Sep. Dose Response. 2020. PMID: 32782450 Free PMC article.
-
Optimized Chitosan/Anion Polyelectrolyte Complex Based Inserts for Vaginal Delivery of Fluconazole: In Vitro/In Vivo Evaluation.Pharmaceutics. 2018 Nov 12;10(4):227. doi: 10.3390/pharmaceutics10040227. Pharmaceutics. 2018. PMID: 30424501 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources